Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.
about
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseCRISPR/Cas9: at the cutting edge of hepatology.Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease.Interferon-α adjuvant therapy decreases the recurrence of early clear cell renal cell carcinoma and improves the prognosis of Chinese patients.
P2860
Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic manipulation of the Ap ...... signaling in atherosclerosis.
@en
Genetic manipulation of the Ap ...... signaling in atherosclerosis.
@nl
type
label
Genetic manipulation of the Ap ...... signaling in atherosclerosis.
@en
Genetic manipulation of the Ap ...... signaling in atherosclerosis.
@nl
prefLabel
Genetic manipulation of the Ap ...... signaling in atherosclerosis.
@en
Genetic manipulation of the Ap ...... signaling in atherosclerosis.
@nl
P2093
P2860
P1433
P1476
Genetic manipulation of the Ap ...... n signaling in atherosclerosis
@en
P2093
Daniel J Rader
David Artis
David W Fields
E John Wherry
Michael C Abt
Robert C Bauer
P2860
P304
P356
10.1016/J.ATHEROSCLEROSIS.2013.12.043
P577
2014-01-10T00:00:00Z